Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism

Clinical Endocrinology

Volumn 68, Issue 5, 2008, Pages 707-715

  Moosgaard, B ^a   Christensen, S E ^a   Vestergaard, P ^a   Heickendorff, L ^a   Christiansen, P ^a   Mosekilde, L ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; BIOLOGICAL MARKER; CALCITRIOL; PARATHYROID HORMONE; VITAMIN D DERIVATIVE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BONE DENSITY; BONE TURNOVER; CAUCASIAN; COHORT ANALYSIS; CORTICAL BONE; FEMALE; FEMUR NECK; FOREARM; FRACTURE; FRAGILITY FRACTURE; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; RISK FACTOR; SPINE FRACTURE; TRABECULAR BONE;

ADULT; AGED; AGED, 80 AND OVER; BONE DENSITY; CALCIFICATION, PHYSIOLOGIC; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MALE; MIDDLE AGED; PARATHYROIDECTOMY; VITAMIN D;

EID: 42149171962     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.03109.x     Document Type: Article

References (51)

1. Rastad, J., Lundgren, E. Ljunghall, S. (2001) Clinical presentation of primary hyperparathyroidism. In : J.P. Bilezikian, R. Marcus, M.A. Levine eds. The Parathyroids: Basic and Clinical Concepts, 2nd edn. Academic Press, San Diego, CA, 361 374.
2. Bilezikian, J.P., Silverberg, S.J., Shane, E., Parisien, M. Dempster, D. (1991) Characterization and evaluation of asymptomatic primary hyperparathyroidism. Journal of Bone and Mineral Research, 6 (Suppl. 2 S85 S89.
3. Adami, S., Braga, V., Squaranti, R., Rossini, M., Gatti, D. Zamberlan, N. (1998) Bone measurements in asymptomatic primary hyperparathyroidism. Bone, 22, 565 570.
4. Christiansen, P., Steiniche, T., Brixen, K., Hessov, I., Melsen, F., Charles, P. Mosekilde, L. (1997) Primary hyperparathyroidism: biochemical markers and bone mineral density at multiple skeletal sites in Danish patients. Bone, 21, 93 99.
5. Guo, C.Y., Thomas, W.E., al Dehaimi. A.W., Assiri, A.M. Eastell, R. (1996) Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism, 81, 3487 3491.
6. Silverberg, S.J., Shane, E., de la, C.L., Dempster, D.W., Feldman, F., Seldin, D., Jacobs, T.P., Siris, E.S., Cafferty, M., Parisien, M.V., Lindsay, R., Clemens, T.L. Bilezikian, J.P. (1989) Skeletal disease in primary hyperparathyroidism. Journal of Bone and Mineral Research, 4, 283 291.
7. Pfeilschifter, J., Siegrist, E., Wuster, C., Blind, E. Ziegler, R. (1992) Serum levels of intact parathyroid hormone and alkaline phosphatase correlate with cortical and trabecular bone loss in primary hyperparathyroidism. Acta Endocrinologica (Copenhagen), 127, 319 323.
8. Marshall, D., Johnell, O. Wedel, H. (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. British Medical Journal, 312, 1254 1259.
9. Melton, L.J., Atkinson, E.J., O'Fallon, W.M. Heath, H 1992) Risk of age-related fractures in patients with primary hyperparathyroidism. Archives of Internal Medicine, 152, 2269 2273.
10. Vestergaard, P., Mollerup, C.L., Frokjaer, V.G., Christiansen, P., Blichert-Toft, M. Mosekilde, L. (2000) Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism. British Medical Journal, 321, 598 602.
11. Nordenstrom, E., Westerdahl, J., Lindergard, B., Lindblom, P. Bergenfelz, A. (2002) Multifactorial risk profile for bone fractures in primary hyperparathyroidism. World Journal of Surgery, 26, 1463 1467.
12. Mezquita-Raya, P., Munoz-Torres, M., Luna, J.D.D., Luna, V., Lopez-Rodriguez, F., Torres-Vela, E. Escobar-Jiménez, F. (2001) Relation between vitamin D insufficiency, bone density, and bone metabolism in healthy postmenopausal women. American Society for Bone and Mineral Research, 16, 1408 1415.
13. Collins, D., Jasani, C., Fogelman, I. Swaminathan, R. (1997) Vitamin D and bone mineral density. European Foundation for Osteoporosis and the National Osteoporosis Foundation, 8, 110 114.
14. Moosgaard, B., Vestergaard, P., Heickendorff, L., Melsen, F., Christiansen, P. Mosekilde, L. (2005) Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Clinical Endocrinology, 63, 506 513.
15. Silverberg, S.J., Shane, E., Dempster, D.W. Bilezikian, J.P. (1999) The effects of vitamin D insufficiency in patients with primary hyperparathyroidism. American Journal of Medicine, 107, 561 567.
16. Yamashita, H., Noguchi, S., Uchino, S., Watanabe, S., Koike, E., Murakami, T., Fujihira, T., Koga, Y., Masatsugu, T. Yamashita, H. (2002) Vitamin D status in Japanese patients with hyperparathyroidism: seasonal changes and effect on clinical presentation. World Journal of Surgery, 26, 937 941.
17. Christiansen, P., Steiniche, T., Brixen, K., Hessov, I., Melsen, F., Heickendorff, L. Mosekilde, L. (1999) Primary hyperparathyroidism. Short-term changes in bone remodeling and bone mineral density following parathyroidectomy. Bone, 25, 237 244.
18. Silverberg, S.J., Gartenberg, F., Jacobs, T.P., Shane, E., Siris, E., Staron, R.B., McMahon, D.J. Bilezikian, J.P. (1995) Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism, 80, 729-734.
19. Nordenstrom, E., Westerdahl, J. Bergenfelz, A. (2004) Recovery of bone mineral density in 126 patients after surgery for primary hyperparathyroidism. World Journal of Surgery, 28, 502 507.
20. Sitges-Serra, A., Girvent, M., Pereira, J.A., Jimeno, J., Nogues, X., Cano, F.J. Sancho, J.J. (2004) Bone mineral density in menopausal women with primary hyperparathyroidism before and after parathyroidectomy. World Journal of Surgery, 28, 1148 1152.
21. Souberbielle, J.C., Cormier, C., Kindermans, C., Gao, P., Cantor, T., Forette, F. Baulieu, E.E. (2001) Vitamin D status and redefining serum parathyroid hormone reference range in the elderly. Journal of Clinical Endocrinology and Metabolism, 86, 3086 3090.
22. Souberbielle, J.C., Lawson-Body, E., Hammadi, B., Sarfati, E., Kahan, A. Cormier, C. (2003) The use in clinical practice of parathyroid hormone normative values established in vitamin d-sufficient subjects. Journal of Clinical Endocrinology and Metabolism, 88, 3501 3504.
23. Moosgaard, B., Vestergaard, P., Heickendorff, L. Mosekilde, L. (2007) Plasma 1,25-dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function. Clinical Endocrinology, 66, 35 42.
24. Andersen, T.F., Madsen, M., Jorgensen, J., Mellemkjoer, L. Olsen, J.H. (1999) The Danish National Hospital Register. A valuable source of data for modern health sciences. Danish Medical Bulletin, 46, 263 268.
25. Vestergaard, P. Mosekilde, L. (2002) Fracture risk in patients with celiac disease, Crohn's disease, and ulcerative colitis: a nationwide follow-up study of 16 416 patients in Denmark. American Journal of Epidemiology, 156, 1 10.
26. Carnevale, V., Manfredi, G., Romagnoli, E., De Geronimo, S., Paglia, F., Pepe, J., Scillitani, A., D'Erasmo, E. Minisola, S. (2004) Vitamin D status in female patients with primary hyperparathyroidism: does it play a role in skeletal damage? Clinical Endocrinology, 60, 81 86.
27. Kantorovich, V., Gacad, M.A., Seeger, L.L. Adams, J.S. (2000) Bone mineral density increases with vitamin D repletion in patients with coexistent vitamin D insufficiency and primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism, 85, 3541 3543.
28. Parfitt, A.M. (1998) Osteomalacia and related disorders. In : L.V. Avioli, S.M. Krane eds. Metabolic Bone Diseases and Clinically Related Disorders. Academic Press, SanDiego, CA, 327 386.
29. Lips, P., Wiersinga, A., van Ginkel, F.C., Jongen, M.J., Netelenbos, J.C., Hackeng, W.H., Delmas, P.D. van der Vijgh, W.J. (1988) The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects. Journal of Clinical Endocrinology and Metabolism, 67, 644 650.
30. Mosekilde, L. (2005) Vitamin D and the elderly. Clinical Endocrinology, 62, 265 281.
31. Parfitt, A.M. (2005) Vitamin D and the pathogenesis of rickets and osteomalacia. In : D. Feldman, J.W. Pike, F.H. Glorieux eds. Vitamin D. Elsevier Academic Press, San Diego, CA, 1029 1048.
32. Segersten, U., Correa, P., Hewison, M., Hellman, P., Dralle, H., Carling, T., Akerstrom, G. Westin, G. (2002) 25-hydroxyvitamin D (3)-1α- hydroxylase expression in normal and pathological parathyroid glands. Journal of Clinical Endocrinology and Metabolism, 87, 2967 2972.
33. Zehnder, D., Bland, R., Williams, M.C., McNinch, R.W., Howie, A.J., Stewart, P.M. Hewison, M. (2001) Extrarenal expression of 25-hydroxyvitamin D (3)-1α-hydroxylase. Journal of Clinical Endocrinology and Metabolism, 86, 888 894.
34. Lumb, G.A. Stanbury, S.W. (1974) Parathyroid function in human vitamin D deficiency and vitamin D deficiency in primary hyperparathyroidism. American Journal of Medicine, 56, 833 839.
35. Rao, D.S., Honasoge, M., Divine, G.W., Phillips, E.R., Lee, M.W., Ansari, M.R., Talpos, G.B. Parfitt, A.M. (2000) Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications. Journal of Clinical Endocrinology and Metabolism, 85, 1054 1058.
36. Nomura, R., Sugimoto, T., Tsukamoto, T., Yamauchi, M., Sowa, H., Chen, Q., Yamaguchi, T., Kobayashi, A. Chihara, K. (2004) Marked and sustained increase in bone mineral density after parathyroidectomy in patients with primary hyperparathyroidism; a six-year longitudinal study with or without parathyroidectomy in a Japanese population. Clinical Endocrinology, 60, 335 342.
37. Silverberg, S.J., Gartenberg, F., Jacobs, T.P., Shane, E., Siris, E., Staron, R.B. Bilezikian, J.P. (1995) Longitudinal measurements of bone density and biochemical indices in untreated primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism, 80, 723 728.
38. Vestergaard, P., Mollerup, C.L., Frøkjær, V.G., Christiansen, P., Blichert-Toft, M. Mosekilde, L. (2003) Cardiovascular events before and after surgery for primary hyperparathyroidism. World Journal of Surgery, 27, 216 222.
39. Bergenfelz, A., Lindergard, B. Ahren, B. (1992) Biochemical variables associated with bone density in patients with primary hyperparathyroidism. European Journal of Surgery, 158, 473 476.
40. Bergenfelz, A., Lindergard, B. Ahren, B. (1993) Prediction of changes in bone density after operation for primary hyperparathyroidism. Annals of Chiropractic Gynaecology, 82, 245 249.
41. de Vernejoul, M.C., Benamout, M.P., Cancela, L., Miravet, L., Kuntz, D., Gueris, J. Gardin, J.P. (1988) Primary hyperparathyroidism seen in rheumatology. Clinical manifestations and relationship between bone history and biological parameters. Revue du Rhumatisme et des Maladies Osteo-Articulaires, 55, 489 494.
42. Lalor, B.C., Mawer, E.B., Davies, M., Lumb, G.A., Hunt, L. Adams, P.H. (1989) Determinants of the serum concentration of 1,25-dihydroxyvitamin D in primary hyperparathyroidism. Clinical Science, 76, 81 86.
43. Mosekilde, L., Charles, P. Lindegreen, P. (1989) Determinants for serum 1,25-dihydroxycholecalciferol in primary hyperparathyroidism. Bone and Mineral, 5, 279 290.
44. Thakker, R.V., Fraher, L.J., Adami, S., Karmali, R. O'Riordan, J.L. (1986) Circulating concentrations of 1,25-dihydroxyvitamin D3 in patients with primary hyperparathyroidism. Bone and Mineral, 1, 137 144.
45. Yasuda, H., Higashio, K. Suda, T. (2005) Vitamin D and osteoclastogenesis. In : D. Feldman, J.W. Pike, F.H. Glorieux eds. Vitamin D. Academic Press, Amsterdam, 665 685.
46. Suda, T., Ueno, Y., Fujii, K. Shinki, T. (2003) Vitamin D and bone. Journal of Cell Biochemistry, 88, 259 266.
47. Kobayashi, K., Imanishi, Y., Miyauchi, A., Onoda, N., Kawata, T., Tahara, H., Goto, H., Miki, T., Ishimura, E., Sugimoto, T., Ishikawa, T., Inaba, M. Nishizawa, Y. (2006) Regulation of plasma fibroblast growth factor 23 by calcium in primary hyperparathyroidism. European Journal of Endocrinology, 154, 93 99.
48. Liu, S., Gupta, A. Quarles, L.D. (2007) Emerging role of fibroblast growth factor 23 in a bone-kindey axis regulating systemic phosphate homeostasis and extracellular matrix mineralization. Current Opinion in Nephrology and Hypertension, 16, 329 335.
49. Rao, D.S., Phillips, E.R., Divine, G.W. Talpos, G.B. (2004) Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism, 89, 5415 5422.
50. Woodhouse, N.J., Doyle, F.H. Joplin, G.F. (1971) Vitamin-D deficiency and primary hyperparathyroidism. Lancet, 2, 283 286.
51. Grey, A., Lucas, J., Horne, A., Gamble, G., Davidson, J.S. Reid, I.R. (2005) Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency. Journal of Clinical Endocrinology and Metabolism, 90, 2122 2126.